“Metagenomic Next-Generation Sequencing Technology Identifies Wider Range of Pathogens in Bronchiectasis Patients, Improving Antibiotic Therapy”

https://pubmed.ncbi.nlm.nih.gov/38115299

This study found that using metagenomic next-generation sequencing (mNGS) technology can identify a wider range of pathogens, including viruses, fungi, and mycoplasma, in patients with acute exacerbations of bronchiectasis, which could improve the effectiveness of antibiotic therapy.